StockTipsArenaBeta

BUY Piramal Pharma Limited — Nuvama Wealth

BUYPiramal Pharma Limited
Piramal Pharma share price target & all analyst calls

byNuvama WealthHorizon: NA (inferred 1 year)30 Jan 2025via Institutional / Brokerage Research

Entry₹231.25Inferred
Target₹283
Total upside +22.38% (call closed)
Stop lossNot given
At expiry₹154.6830 Jan 2026, 3:30 pm
Expired-33.11%
Follow Nuvama Wealth for new calls(69% target hit, 144 closed calls)Get alertsWatch PPLPHARMA for new buy/sell callsGet alertsSee 5 active Long-term calls on PPLPHARMASee 209 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 12:57 pm IST
1 supporting0 opposing
Supports the BUY call (1)

2 other SEBI-registered advisors have active long-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·30 Jan · today

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Piramal Pharma

All analyst calls on Piramal Pharma

More from Nuvama Wealth

Every call and its outcome